Variantyx
Latest round
- Series D
Last raised
- Apr 2024
Total raised
- $99M
Investors
- 8
About Variantyx
Established in 2014 by Haim Neerman and Tomer Jackman, and based in Massachusetts, US, Variantyx, Inc. is a medical firm that offers diagnostics for the treatment of rare genetic illnesses, reproductive genetics, and oncology therapy optimization. In April 2024, Variantyx, Inc. Variantyx provides advanced molecular diagnostic solutions using whole genome sequencing. The firm’s offerings include diagnostic testing for rare genetic disorders, reproductive genetics, tumor profiling in oncology through OncoAlly™, wellness testing for general health, and genomic profiling for pharmaceutical research. The platform integrates multiple types of genetic data to deliver comprehensive insights from a single sample, aiding in accurate diagnosis and treatment optimization.
Who invested in Variantyx
8 investors across 4 rounds
See all investors in Variantyx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Variantyx
Who invested in Variantyx?
Variantyx has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Variantyx raised?
Variantyx has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Variantyx last raise money?
Variantyx's most recent round on record is a Series D, in Apr 2024.
What does Variantyx do?
Established in 2014 by Haim Neerman and Tomer Jackman, and based in Massachusetts, US, Variantyx, Inc.
Where is Variantyx headquartered?
Variantyx is headquartered in Framingham, US.
Which VCs invest in companies like Variantyx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Variantyx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Variantyx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.